Overview of Edwards Lifesciences operations within healthcare technology, covering medical devices, structural heart ...

Four large-cap MedTech leaders, MDT, ISRG, CAH, EW, appear well-positioned to extend their winning streaks in 2026 on resilient procedure demand and innovation.

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA ...

Mitchell Grant is a self-taught investor with over 5 years of experience as a financial trader. He is a financial content strategist and creative content editor. Khadija Khartit is a strategy, ...

Short-term mortality outcomes in shock were noninferior among critically ill patients managed without vs with early arterial catheter insertion.

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Thomas J Catalano is a CFP and Registered Investment Adviser with the state of ...

New ACC/AHA guidelines provide updated management strategies for the growing population of adults living with congenital heart disease.

Perinatal acute care is associated with specific clinical demands and challenges. The relatively small number of acute care cases occurring in many institutions, together with the presence of senior ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approv ...

Cybersecurity is more important than ever, as cybercrime losses reached $16.6 billion in 2024, according to the FBI, a staggering 33% uptick from 2023. Credit monitoring services protect your personal ...

If you plan on getting involved in day trading, then having access to reliable and feature-rich charting platforms can be an essential tool. With numerous day trading chart providers available in the ...